Sagimet Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:0O2 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Jul 24Sell€40,051George KembleIndividual14,062€2.85
19 Jul 24Sell€31,073Elizabeth RozekIndividual10,914€2.85
19 Jul 24Sell€23,798Eduardo MartinsIndividual8,357€2.85
26 Mar 24Buy€58,868David HappelIndividual12,100€4.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0O2?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,654,7015.14%
Hedge Funds2,393,9287.44%
Individual Insiders3,219,23910%
VC/PE Firms5,573,62717.3%
General Public5,690,64317.7%
Institutions13,663,20742.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 74.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.44%
Point72 Asset Management, L.P.
2,393,928€11.8m1.18%0.03%
6.21%
New Enterprise Associates, Inc.
2,000,275€9.9m0%0.53%
5.9%
Kleiner Perkins Caufield & Byers
1,899,475€9.4m0%1.88%
5.2%
CHI Advisors LLC
1,673,877€8.3m0%4.36%
5.14%
Jinzi Jason Wu
1,654,701€8.2m0%no data
5.14%
Ascletis Pharma Inc.
1,654,701€8.2m0%no data
4.78%
Baker Bros. Advisors LP
1,538,489€7.6m-47%0.08%
4.28%
Alyeska Investment Group, L.P.
1,378,358€6.8m7.82%0.03%
3.78%
Citadel Advisors LLC
1,215,871€6.0m1.75%0.01%
3.3%
Rushu Luo
1,062,998€5.2m0%no data
3.25%
The Vanguard Group, Inc.
1,047,540€5.2m-2.48%no data
2.96%
BlackRock, Inc.
952,591€4.7m5.37%no data
2.45%
Rock Springs Capital Management LP
787,808€3.9m0%0.13%
2.25%
Hillhouse Investment Management, Ltd.
724,800€3.6m0%0.04%
2.25%
Artal Group S.A.
724,771€3.6m0%0.11%
2.02%
PFM Health Sciences, LP
649,006€3.2m0%0.21%
1.68%
Bank of America Corporation, Asset Management Arm
540,307€2.7m9.18%no data
1.2%
Ikarian Capital, LLC
387,565€1.9m-6.06%0.57%
0.84%
Morgan Stanley, Investment Banking and Brokerage Investments
271,432€1.3m-19.9%no data
0.82%
Marshall Wace LLP
263,541€1.3m0%no data
0.8%
Dennis Hom
257,569€1.3m0%no data
0.78%
Geode Capital Management, LLC
252,298€1.2m56.7%no data
0.72%
Renaissance Technologies LLC
231,100€1.1m-4.66%no data
0.6%
Millennium Management LLC
194,153€958.9k-66.3%no data
0.59%
Duke Management Company
189,394€935.4k0%2.33%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 10:41
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sagimet Biosciences Inc. is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrea TanGoldman Sachs
Andrea NewkirkGoldman Sachs
Antonio ArceH.C. Wainwright & Co.